As Of | | | Filer / Issuer | Symbol† (Prices) | Latest Filings | SIC (Latest) |
---|
| | | | As: Filer | Re: Issuer |
---|
Active in the Past Year (since 4/25/23) in Industry 2835: |
---|
4/23/24 | | | Achieve Life Sciences, Inc. | ACHV | S-8 | 4 | 2835 |
---|
4/1/24 | | | Alpha Teknova, Inc. | TKNO | 8-K | 4 | 2835 |
---|
4:27p ET | | | ARCA biopharma, Inc. | ABIO | 425 | 425 | 2835 |
---|
4/22/24 | | | Aspira Women’s Health Inc. [ formerly Vermillion, Inc. ] | AWH | S-3 | SC 13G/A | 2835 |
---|
4/12/24 | | | Biomerica Inc. | BMRA | 10-Q | SC 13G/A | 2835 |
---|
1/16/24 | | | Burzynski Research Institute Inc. | BZYR | 10-Q | 3 OLD | 2835 |
---|
4/8/24 | | | Cardio Diagnostics Holdings, Inc. [ formerly Mana Capital Acquisition Corp. ] | CDIO | 8-K | 4 | 2835 |
---|
4:05p ET | | | Celldex Therapeutics, Inc. | CLDX | ARS | 4 | 2835 |
---|
6/23/23 | | | Heska Corp. | 15-12G | 4 | 2835 |
---|
2/2/24 | | | Hougen Elizabeth L | 4 | — | 2835 |
---|
3/27/24 | | | IDEXX Laboratories, Inc. | IDXX | ARS | 4 | 2835 |
---|
4/10/24 | | | Immucell Corp./DE | ICCC | EFFECT | 4 | 2835 |
---|
4/22/24 | | | Intellia Therapeutics, Inc. | NTLA | PRE 14A | 3 | 2835 |
---|
4/19/24 | | | Lantheus Holdings, Inc. | LNTH | ARS | 4 | 2835 |
---|
10/4/23 | | | Lucira Health, Inc. | 15-12G | 25-NSE OLD | 2835 |
---|
5/9/23 | | | MDNA Life Sciences, Inc. | S-1/A | — | 2835 |
---|
4/18/24 | | | MyMD Pharmaceuticals, Inc. [ formerly Akers Biosciences, Inc. ] | MYMD | 8-K | SC 13G | 2835 |
---|
4:18p ET | | | Myriad Genetics Inc. | MYGN | ARS | SC 13G | 2835 |
---|
2/5/24 | | | Navidea Biopharmaceuticals, Inc. | NAVB | EFFECT | SC 13D/A | 2835 |
---|
4/24/24 | | | Neogen Corp. | NEOG | 10-Q | 4 | 2835 |
---|
| | More... Please Sign In to list all of them. |
________ † Market: Symbols source: SEC — Prices: Nasdaq , NYSE , or . |
|